These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31530856)

  • 21. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
    David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
    Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
    Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
    J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of the Alk1 extracellular domain and characterization of its bone morphogenetic protein (BMP) binding properties.
    Mahlawat P; Ilangovan U; Biswas T; Sun LZ; Hinck AP
    Biochemistry; 2012 Aug; 51(32):6328-41. PubMed ID: 22799562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
    Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.
    Wei Z; Salmon RM; Upton PD; Morrell NW; Li W
    J Biol Chem; 2014 Nov; 289(45):31150-9. PubMed ID: 25237187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
    Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
    J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
    Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival.
    Addante A; Roncero C; Lazcanoiturburu N; Méndez R; Almalé L; García-Álvaro M; Ten Dijke P; Fabregat I; Herrera B; Sánchez A
    Cells; 2020 Mar; 9(3):. PubMed ID: 32204446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SEMA3G regulates BMP9 inhibition of VEGF-mediated migration and network formation in pulmonary endothelial cells.
    Mirza SL; Upton PD; Hodgson J; Gräf S; Morrell NW; Dunmore BJ
    Vascul Pharmacol; 2024 Jun; 155():107381. PubMed ID: 38795838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
    Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD
    Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
    van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
    J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
    J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial
    Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFβ1.
    van Caam A; Blaney Davidson E; Garcia de Vinuesa A; van Geffen E; van den Berg W; Goumans MJ; ten Dijke P; van der Kraan P
    Osteoarthritis Cartilage; 2015 Jun; 23(6):985-95. PubMed ID: 25681563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
    Quist-Løkken I; Andersson-Rusch C; Kastnes MH; Kolos JM; Jatzlau J; Hella H; Olsen OE; Sundan A; Knaus P; Hausch F; Holien T
    Cell Commun Signal; 2023 Jan; 21(1):25. PubMed ID: 36717825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.
    Herhaus L; Al-Salihi MA; Dingwell KS; Cummins TD; Wasmus L; Vogt J; Ewan R; Bruce D; Macartney T; Weidlich S; Smith JC; Sapkota GP
    Open Biol; 2014 May; 4(5):140065. PubMed ID: 24850914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.
    Lee HW; Chong DC; Ola R; Dunworth WP; Meadows S; Ka J; Kaartinen VM; Qyang Y; Cleaver O; Bautch VL; Eichmann A; Jin SW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):657-663. PubMed ID: 28232325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.